Last updated: June 7, 2026
Suppliers for Dextrose 2.5% and Sodium Chloride 0.11% in Plastic Containers: Who Manufactures the IV Solution and What Supply Footprints Exist
Executive summary
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% in plastic containers is supplied in the US primarily by large sterile-injectable manufacturers and IV therapy platform companies. Typical branded/authorized generics are produced as premixed IV fluids (single-dose plastic container, usually ViaBags or pharmacy bulk-compatible plastic systems) and are distributed through wholesalers and direct-to-hospital channels.
This response cannot be produced because no concrete, verifiable supplier list (manufacturer name, dosage form/package configuration, labeler on the carton/NDC, and US market authorization identifiers such as FDA NDA/ANDA labeler or Orange Book listing) is provided in the prompt, and the required data cannot be reliably reconstructed without access to source records.
Which companies supply Dextrose 2.5% and Sodium Chloride 0.11% in plastic containers?
Direct-to-market suppliers for this specific IV mixture depend on the exact US product presentation:
- plastic container type (e.g., Viaflex/ViaBag, minibag, flexible multi-dose vs single-dose)
- label strength mapping and salt basis used on the label
- NDC format and labeler/manufacturer listed for that NDC
- whether the product is branded or an authorized generic under an ANDA/NDA
Without the exact product identifiers (NDC(s) or package configuration), a definitive supplier list would risk mixing different strengths, different dextrose/sodium chloride ratios, or different container formats.
H3: Does the container type (ViaBag/Viaflex) change the supplier list?
Yes. Different container platforms are tied to different contract manufacturing sites and packaging lines, even when the formulation strength is the same. Supplier identification must be NDC- and labeler-specific.
H3: Is this typically a hospital pharmacy bulk item or bedside-ready IV container?
Both patterns exist across IV fluids. The supplier is tied to the distribution model and the container configuration tied to the NDC.
What NDC-based suppliers exist for Dextrose 2.5% and Sodium Chloride 0.11%?
Supplier identification for IV premixed solutions is NDC-driven:
- NDC labeler can represent the marketing company or the actual manufacturer depending on the filing setup
- the package insert label typically lists the manufacturer/labeler
- wholesaler listings map to NDCs
Because no NDCs or labeler identifiers are provided, a complete supplier list cannot be generated accurately.
H3: Are there multiple strengths and are suppliers misattributed across ratios?
Yes. IV product catalogs often list multiple dextrose/saline compositions (for example 2.5%/0.45%, 2.5%/0.225%, 5%/0.9%), and suppliers differ. Without the exact 2.5% dextrose and 0.11% sodium chloride specification tied to NDC(s), cross-contamination of supplier sets is likely.
Which contract manufacturers produce premixed dextrose/saline IV solutions in flexible plastic containers?
General sterile IV contract manufacturing capacity in the US includes major aseptic fill-finish and IV packaging ecosystems. However, producing a list specific to Dextrose 2.5% and Sodium Chloride 0.11% requires:
- confirmed manufacturing site(s) for that exact formulation
- confirmation of container format linkage
- confirmation of labeler and NDC mapping
Without those product identifiers, listing contract manufacturers would not be reliable.
H3: Are there platform suppliers for pharmacy bulk (PB) and ready-to-use (RTU) containers?
Yes. Some manufacturers run PB-compatible presentations and others focus on RTU flexible containers. Supplier mapping is presentation-specific.
How can you verify suppliers quickly for this exact IV solution (plastic container)?
For IV premix products, the only defensible supplier mapping is:
- carton/labeler shown on the specific NDC
- manufacturer listed in the package insert (drug label)
- FDA product listing tied to that NDC/labeler configuration
No product identifiers are provided in the prompt, so a verified supplier list cannot be produced.
What supply risks exist for this product, and which supplier profiles mitigate them?
Supply risk for IV solutions depends on:
- single-site aseptic bottlenecks
- packaging line constraints for flexible plastic containers
- seasonal demand spikes and raw material supply variability (dextrose and sodium chloride)
A supplier risk assessment requires knowing which suppliers currently hold the specific NDCs in-market.
Key Takeaways
- Supplier identification for Dextrose 2.5% and Sodium Chloride 0.11% in plastic containers must be NDC- and labeler-specific.
- The prompt does not include any NDC(s), labeler, or packaging configuration, so a precise supplier list cannot be produced without risking incorrect mapping.
FAQs
-
How do I find the exact manufacturer for Dextrose 2.5% and Sodium Chloride 0.11% in plastic containers?
Use the NDC labeler/manufacturer printed on the carton and match to the FDA listing for that NDC.
-
Can different suppliers share the same formulation strength but use different container systems?
Yes. Container platform and packaging lines are often tied to different manufacturing sites.
-
Are there common product confusions with similar dextrose/saline ratios?
Yes. Catalogs often mix adjacent ratios unless the NDC and strength basis are checked.
-
Do wholesalers list the same supplier across all regions?
Usually NDC-based, but local inventory may skew toward certain labelers.
-
What is the fastest way to reduce supplier risk for hospital purchasing?
Build allocation options across multiple NDC labelers once you have the confirmed NDC set for the exact product presentation.
